Arevik Ghazaryan, PhD, DMLI(ASCP)

Assistant Professor (Clinical), University of Utah School of Medicine

Specialties

• Immunodeficiency
• Autoimmunity

Education

• Doctorate Degree—Microbiology and Immunology, University of Utah School of Medicine
• Fellowship—Immunology, Oncology, Huntsman Cancer Institute
• Fellowship—Clinical Immunology, University of Utah and ARUP Laboratories

Certifications/Affiliations

• American Society for Clinical Pathology (Medical Laboratory Immunology Diplomate)
• Association of Medical Laboratory Immunologists
• Clinical Immunology Society

Research Interests

• Immunodeficiency
• Autoimmunity

Awards

• AMLI Future Leaders in Medical Laboratory Immunology Award, 2026

Recent Publications

• Battistone B, Ghazaryan A, Tang WW, et al. T-cell miR-155 regulates the response to tumor-specific mRNA vaccines in a murine model of acute myeloid leukemia. J Immunol. 2026; 215(7):vkag184. 
• Nelson MC, O'Malley LC, Lee SH, et al. MicroRNA-146a protects against hepatocellular carcinoma through suppression of CCL5. Cancer Res Commun. 2026;6(2):359-373. 
• Tang WW, Battistone B, Bauer KM, et al. A microRNA-regulated transcriptional state defines intratumoral CD8(+) T cells that respond to immunotherapy. Cell Rep. 2025;44(2):115301. 
• Blanchard Z, Brown EA, Ghazaryan A, et al. PDX models for functional precision oncology and discovery science. Nat Rev Cancer. 2025;25(3):153-166. 
• Ren JG, Xing B, Lv K, et al. RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. J Clin Invest. 2023;133(12):e165510. 
• Ghazaryan A, Wallace JA, Tang WW, et al. miRNA-1 promotes acute myeloid leukemia cell pathogenesis through metabolic regulation. Front Genet. 2023;14:1192799. 
• Thompson JW, Hu R, Huffaker TB, e al. MicroRNA-155 Plays selective cell-intrinsic roles in brain-infiltrating immune cell populations during neuroinflammation. J Immunol. 2023;210(7):926-934. 
• Barba C, Ekiz HA, Tang WW, et al. Interferon gamma-inducible NAMPT in melanoma cells serves as a mechanism of resistance to enhance tumor growth. Cancers (Basel). 2023;15(5):1411. 
• Bauer KM, Nelson MC, Tang WW, et al. CD11c+ myeloid cell exosomes reduce intestinal inflammation during colitis. JCI Insight. 2022;7(19):e159469.
• Stephens WZ, Kubinak JL, Ghazaryan A, et al. Epithelial-myeloid exchange of MHC class II constrains immunity and microbiota composition. Cell Rep. 2021;37(5):109916.